U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry ACHIRAL
Molecular Formula C7H7ClN6O2
Molecular Weight 242.622
Optical Activity NONE
Defined Stereocenters 0 / 0
E/Z Centers 0
Charge 0

SHOW SMILES / InChI
Structure of MITOZOLOMIDE

SMILES

NC(=O)C1=C2N=NN(CCCl)C(=O)N2C=N1

InChI

InChIKey=QXYYYPFGTSJXNS-UHFFFAOYSA-N
InChI=1S/C7H7ClN6O2/c8-1-2-14-7(16)13-3-10-4(5(9)15)6(13)11-12-14/h3H,1-2H2,(H2,9,15)

HIDE SMILES / InChI

Molecular Formula C7H7ClN6O2
Molecular Weight 242.622
Charge 0
Count
Stereochemistry ACHIRAL
Additional Stereochemistry No
Defined Stereocenters 0 / 0
E/Z Centers 0
Optical Activity NONE

Mitozolomide is an antineoplastic agent patented by May and Baker Ltd for cancer treatment. Development of mitozolomide was discontinued during Phase II clinical trials after it was found to cause severe and unpredictable bone marrow suppression.

Approval Year

PubMed

PubMed

TitleDatePubMed
A novel human recombinant single-chain antibody targeting CD166/ALCAM inhibits cancer cell invasion in vitro and in vivo tumour growth.
2010-11
A cyclic-RGD-BioShuttle functionalized with TMZ by DARinv "Click Chemistry" targeted to αvβ3 integrin for therapy.
2010-09-21
Acquired resistance to temozolomide in glioma cell lines: molecular mechanisms and potential translational applications.
2010
Dexamethasone protected human glioblastoma U87MG cells from temozolomide induced apoptosis by maintaining Bax:Bcl-2 ratio and preventing proteolytic activities.
2004-12-08
Sustained antiproliferative mechanisms by RB24, a targeted precursor of multiple inhibitors of epidermal growth factor receptor and a DNA alkylating agent in the A431 epidermal carcinoma of the vulva cell line.
2004-09-13
Professor Tom Connors and the development of novel cancer therapies by the Phase I/II Clinical Trials Committee of Cancer Research UK.
2003-08-04
Pyrrolo[2,1-d][1,2,3,5]tetrazine-4(3H)-ones, a new class of azolotetrazines with potent antitumor activity.
2003-05-29
Marked inactivation of O6-alkylguanine-DNA alkyltransferase activity with protracted temozolomide schedules.
2003-04-07
Antitumor imidazotetrazines. 41. Conjugation of the antitumor agents mitozolomide and temozolomide to peptides and lexitropsins bearing DNA major and minor groove-binding structural motifs.
2002-12-05
The sensitivity of MCF10A breast epithelial cells to alkylating drugs is enhanced by the inhibition of O6-methylguanine-DNA methyltransferase transcription with a synthetic double strand DNA oligonucleotide.
2002-06
Synthesis and antibacterial activity of dual-action agents of a beta-lactam antibiotic with cytotoxic agent mitozolomide or temozolomide.
2002-04
Ribozyme and free alkylated base: a dual approach for sensitizing Mex+ cells to the alkylating antineoplastic drug.
2000-06
Transient transfection of a synthetic hammerhead ribozyme targeted against human MGMT gene to cells in culture potentiates the genotoxicity of the alkylation damage induced by mitozolomide.
1999-04
Tetrazepinones are equally cytotoxic to Mer+ and Mer- human tumor cell lines.
1999-02
Recombinant adeno-associated virus-mediated expression of O6-alkylguanine-DNA-alkyltransferase protects human epithelial and hematopoietic cells against chloroethylating agent toxicity.
1999-01-20
Patents

Patents

Sample Use Guides

100 mg/m^2 every 6 weeks.
Route of Administration: Intravenous
Substance Class Chemical
Created
by admin
on Mon Mar 31 18:29:39 GMT 2025
Edited
by admin
on Mon Mar 31 18:29:39 GMT 2025
Record UNII
E3U7286V3W
Record Status Validated (UNII)
Record Version
  • Download
Name Type Language
MITOZOLOMIDE
INN  
INN  
Official Name English
NSC-353451
Preferred Name English
mitozolomide [INN]
Common Name English
3-(2-CHLOROETHYL)-3,4-DIHYDRO-4-OXOIMIDAZO(5,1-D)-AS-TETRAZINE-8-CARBOXAMIDE
Common Name English
Classification Tree Code System Code
NCI_THESAURUS C902
Created by admin on Mon Mar 31 18:29:39 GMT 2025 , Edited by admin on Mon Mar 31 18:29:39 GMT 2025
Code System Code Type Description
EPA CompTox
DTXSID40234862
Created by admin on Mon Mar 31 18:29:39 GMT 2025 , Edited by admin on Mon Mar 31 18:29:39 GMT 2025
PRIMARY
ECHA (EC/EINECS)
287-943-3
Created by admin on Mon Mar 31 18:29:39 GMT 2025 , Edited by admin on Mon Mar 31 18:29:39 GMT 2025
PRIMARY
WIKIPEDIA
MITOZOLOMIDE
Created by admin on Mon Mar 31 18:29:39 GMT 2025 , Edited by admin on Mon Mar 31 18:29:39 GMT 2025
PRIMARY
FDA UNII
E3U7286V3W
Created by admin on Mon Mar 31 18:29:39 GMT 2025 , Edited by admin on Mon Mar 31 18:29:39 GMT 2025
PRIMARY
NSC
353451
Created by admin on Mon Mar 31 18:29:39 GMT 2025 , Edited by admin on Mon Mar 31 18:29:39 GMT 2025
PRIMARY
EVMPD
SUB09013MIG
Created by admin on Mon Mar 31 18:29:39 GMT 2025 , Edited by admin on Mon Mar 31 18:29:39 GMT 2025
PRIMARY
PUBCHEM
71766
Created by admin on Mon Mar 31 18:29:39 GMT 2025 , Edited by admin on Mon Mar 31 18:29:39 GMT 2025
PRIMARY
MESH
C040369
Created by admin on Mon Mar 31 18:29:39 GMT 2025 , Edited by admin on Mon Mar 31 18:29:39 GMT 2025
PRIMARY
SMS_ID
100000080881
Created by admin on Mon Mar 31 18:29:39 GMT 2025 , Edited by admin on Mon Mar 31 18:29:39 GMT 2025
PRIMARY
NCI_THESAURUS
C1166
Created by admin on Mon Mar 31 18:29:39 GMT 2025 , Edited by admin on Mon Mar 31 18:29:39 GMT 2025
PRIMARY
INN
5522
Created by admin on Mon Mar 31 18:29:39 GMT 2025 , Edited by admin on Mon Mar 31 18:29:39 GMT 2025
PRIMARY
ChEMBL
CHEMBL435951
Created by admin on Mon Mar 31 18:29:39 GMT 2025 , Edited by admin on Mon Mar 31 18:29:39 GMT 2025
PRIMARY
CAS
85622-95-3
Created by admin on Mon Mar 31 18:29:39 GMT 2025 , Edited by admin on Mon Mar 31 18:29:39 GMT 2025
PRIMARY
Related Record Type Details
ACTIVE MOIETY